Skip to main content

The Worldwide Nucleic Acid Sample Preparation Industry is Projected to Reach $11.2 Billion by 2032 - ResearchAndMarkets.com

The "Nucleic Acid Sample Preparation Market - A Global and Regional Analysis: Focus on Product, Workflow, Technology, Therapeutic Area, Application, End User, and Region - Analysis and Forecast, 2022-2032" report has been added to ResearchAndMarkets.com's offering.

The global nucleic acid sample preparation market is projected to reach $11,200.5 million by 2032 from $4,213.0 million in 2022, growing at a CAGR of 10.27% during the forecast period 2022-2032.

The growth in the global nucleic acid sample preparation market is expected to be driven by the increased use of nucleic acid molecules in several therapeutic areas.

In addition, the increased demand for downstream applications such as next-generation sequencing (NGS) and others and the advancement in nucleic acid extraction/isolation techniques have driven the growth of the nucleic acid sample preparation market.

Market Lifecycle Stage

The global nucleic acid sample preparation market is in progressing phase. To meet the growing need for timely diagnostic information and targeted patient treatment, several molecular procedures, including automated nucleic acid sample preparation workstations, have been developed.

In addition, sample preparation is essential in precision medicine because it assures the safe and successful use of tailored therapies.

The market offers a range of universal products with varied maximum throughputs, innovations, time durations, and other qualities, and companies are searching for innovative methods to distinguish themselves. Additionally, manufacturers began to produce application-specific nucleic acid purification devices and liquid handlers in recent years.

Impact

One of the main reasons for the anticipated expansion of the nucleic acid sample preparation market in the upcoming years is the rise in the use of nucleic acid molecules in several therapeutic areas. Sample preparation is typically an important phase in the accurate analysis of nucleic acids. Nuclease protection is one of the most important aspects to consider while processing nucleic acid samples. Nucleic acid extraction and isolation is the first stage in the area of molecular biology research, followed by recombinant procedures.

Market Segmentation

Segmentation 1: by Product

  • Systems
  • Consumables
  • Accessories and Components

Segmentation 2: by Workflow

  • Sample Extraction/Isolation
  • Sample Quantification
  • Quality Control
  • Fragmentation
  • Target Enrichment
  • Library Quantification
  • Pooling

Segmentation 3: by Technology

  • Spin-Column Based Technology
  • Magnetic-Bead Based Technology
  • Other Technologies

Segmentation 4: by Therapeutic Area

  • Oncology
  • Human Genetics/Population Genetics
  • Infectious Disease
  • Others

Segmentation 5: by Application

  • Genomics
  • Proteomics
  • Other Applications

Segmentation 6: by End User

  • Academic and Research Institutions
  • Pharmaceutical and Biotechnology Companies
  • Clinical and Diagnostic Laboratories
  • Other End Users

Segmentation 7: by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Rest-of-the-World

Recent Developments in the Global Nucleic Acid Sample Preparation Market

  • In June 2022, Hamilton Company. and Bionano Genomics created a Long String VANTAGE, a brand-new DNA extraction automation product. Ultra-high molecular weight (UHMW) DNA can be extracted with the instrument and used for optical genome mapping (OGM). As a requirement for the sample preparation workflow at Bionano Genomics, high-quality and quantity UHMW DNA extraction is required.
  • In November 2022, RevoluGen, a U.K.-based genomics company, announced that it had entered into an agreement with Tecan Trading AG, a pioneer and industry leader in laboratory automated processes, for the production and supply of Tecan's 96-well filter plates for use in RevoluGen's automated Fire Monkey High Molecular Weight (HMW)-DNA extraction kits.
  • In June 2021, Agilent Technologies, Inc. launched the SureSelect Human All Exon V8. This new exome design offers thorough content and current coverage of protein-coding areas from RefSeq, CCDS, and GENCODE. Additionally, it includes exons that are challenging to capture and the TERT promoter, which is neglected by competing exomes. The new design offers content flexibility to satisfy the demands of customers in three options, i.e., standard exome sequencing (Exome v8), translational research (v8 UTR Plus), and clinical research sequencing (v8 Clinical Plus).
  • In August 2022, the introduction of the QIAseq Targeted DNA Pro Panels and the QIAseq UPXome RNA Library Kit, both of which have set new benchmarks in sample preparation for determining their nucleic acid sequences, allowed QIAGEN N.V. to announce the extension of its next-generation sequencing (NGS) portfolio. The time required for library preparation of DNA samples by researchers is cut in half to six hours due to the QIAseq Targeted DNA Pro Panels' enhanced chemistry.

Demand - Drivers and Limitations

The following are the demand drivers for the global nucleic acid sample preparation market:

  • Increasing Use of Nucleic Acid Molecules in Various Therapeutic Areas
  • Advancement in the Nucleic Acid Extraction/Isolation Techniques
  • Advantages of Automated Sample Preparation Workstations
  • Increasing Demand for Downstream Applications such as Next-Generation Sequencing (NGS)

The market is expected to face some limitations due to the following challenges:

  • High Cost of Automated Workstations
  • Rigid Regulatory Standards

Key Companies Profiled

  • Agilent Technologies, Inc.
  • Aurora Biomed Inc.
  • BGI Group (MGI Tech Co., Ltd.)
  • BIONEER CORPORATION.
  • Blue-Ray Biotech Corp.
  • Danaher. (Beckman Coulter, Inc.)
  • Endress+Hauser Group Services AG (Analytik Jena GmbH)
  • Eppendorf SE
  • F. Hoffmann-La Roche Ltd
  • Illumina, Inc.
  • Merck KGaA
  • Norgen Biotek Corp.
  • OPENTRONS
  • PerkinElmer Inc.
  • Promega Corporation
  • QIAGEN
  • Sansure Biotech Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.

For more information about this report visit https://www.researchandmarkets.com/r/vlrv33-acid?w=4

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.